LH1307
LH1307 is a C2-symmetric inhibitor of PD-1/PD-L1 protein-protein interactions with a IC50 value of 3.0 μM and can be used in cancer studies[1].
Product Specifications
CAS Number
[2375720-38-8]
UNSPSC
12352005
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lh1307.html
Purity
96.9
Solubility
10 mM in DMSO
Smiles
N#CC1=CN=CC(COC2=CC(OCC3=CC=CC(C4=CC=CC(COC5=C(C)C=C(CNCCNC(C)=O)C(OCC6=CC(C#N)=CN=C6)=C5)=C4C)=C3C)=C(C)C=C2CNCCNC(C)=O)=C1
Molecular Formula
C54H58N8O6
Molecular Weight
915.09
References & Citations
[1]Basu S, et al. Design, Synthesis, Evaluation, and Structural Studies of C2-Symmetric Small Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction. J Med Chem. 2019 Aug 8;62 (15) :7250-7263.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Glucocorticoid Receptor (NR3C1) Mouse Monoclonal Antibody [Clone ID: LBI7A3]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
AMM17252VCF 100 µg
Glucocorticoid Receptor (NR3C1) Mouse Monoclonal Antibody [Clone ID: LBI7A3]
Ask
View Details 
